Cymbria Corporation
Cymbria Corporation (CYB.TO) Financial Performance & Income Statement Overview
Explore the financials of Cymbria Corporation (CYB.TO), including yearly and quarterly data on income, cash flow, and balance sheets.
Cymbria Corporation (CYB.TO) Income Statement & Financial Overview
View the income breakdown for Cymbria Corporation CYB.TO across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $51.66M | $19.23M | $139.11M | -$35.31M |
| Cost of Revenue | $763000.00 | $0.00 | $0.00 | $3.79M |
| Gross Profit | $50.89M | $19.23M | $139.11M | -$39.10M |
| Gross Profit Ratio | $0.99 | $1.00 | $1.00 | $1.11 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.97M | $1.05M | $1.64M | $1.03M |
| Operating Expenses | $2.93M | $1.82M | $139.11M | -$35.31M |
| Total Costs & Expenses | $3.69M | $1.82M | $139.11M | -$35.31M |
| Interest Income | $1.39M | $1.49M | $1.39M | $1.45M |
| Interest Expense | $763000.00 | $1.66M | $83000.00 | $1.09M |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $0.00 |
| EBITDA | $47.96M | $17.32M | $136.60M | -$36.86M |
| EBITDA Ratio | $0.93 | $0.90 | $0.98 | $1.04 |
| Operating Income | $47.96M | $17.42M | -$273.37M | -$36.86M |
| Operating Income Ratio | $0.93 | $0.91 | -$1.97 | $1.04 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $409.98M | -$760000.00 |
| Income Before Tax | $47.96M | $17.42M | $136.60M | -$37.62M |
| Income Before Tax Ratio | $0.93 | $0.91 | $0.98 | $1.07 |
| Income Tax Expense | $4.17M | -$21.73M | $22.55M | -$9.30M |
| Net Income | $43.79M | $39.15M | $114.05M | -$28.32M |
| Net Income Ratio | $0.85 | $2.04 | $0.82 | $0.80 |
| EPS | $1.92 | $1.80 | $5.02 | -$1.30 |
| Diluted EPS | $1.92 | $1.80 | $5.02 | -$1.28 |
| Weighted Avg Shares Outstanding | $22.81M | $21.81M | $22.72M | $21.80M |
| Weighted Avg Shares Outstanding (Diluted) | $22.81M | $21.81M | $22.72M | $22.12M |
The company's financials show resilient growth, with revenue advancing from -$35.31M in Q2 2024 to $51.66M in Q1 2025. Gross profit remained healthy with margins at 99% in Q1 2025 compared to 111% in Q2 2024. Operating income hit $47.96M last quarter, sustaining a consistent 93% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $47.96M. Net income rose to $43.79M, while earnings per share reached $1.92. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan